Literature DB >> 28528182

PAQR3 inhibits the proliferation, migration and invasion in human glioma cells.

Shi-Lei Tang1, Yuan-Lin Gao2, Wen-Zhong Hu3.   

Abstract

Progestin and AdipoQ Receptor 3 (PAQR3), a member of the PAQR family, is down-regulated in several types of cancers and has been closely associated with tumor progression and development. However, little is known about the functions of PAQR3 in the tumorigenesis of human glioma. Therefore, in this report, we investigated the role of PAQR3 in human glioma. Our results showed that the expression of PAQR3 was significantly reduced in human glioma tissues and cell lines. PAQR3 overexpression inhibited the proliferation of glioma cells in vitro and attenuated tumor xenograft growth in vivo. In addition, PAQR3 overexpression suppressed the migration and invasion of glioma cells, as well as prevented the EMT process. Mechanistic studies demonstrated that PAQR3 overexpression significantly down-regulated the levels of phosphorylated PI3K and Akt in U251 cells. In conclusion, these results demonstrated that PAQR3 inhibited the proliferation, migration and invasion in glioma cells, at least in part, through the inactivation of PI3K/Akt signaling pathway. Therefore, PAQR3 may be a therapeutic target for the treatment of glioma.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Glioma; Invasion; PAQR3; PI3K/Akt pathway

Mesh:

Substances:

Year:  2017        PMID: 28528182     DOI: 10.1016/j.biopha.2017.05.046

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

Review 1.  Golgi Complex: A Signaling Hub in Cancer.

Authors:  Daniela Spano; Antonino Colanzi
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

2.  Nuclear factor-kappa B1 inhibits early apoptosis of glioma cells by promoting the expression of Bcl-2.

Authors:  Tian-Quan Yang; Min Chen; Yong-Qiang Wang; Wei Xu; Yong Han; Jin Xu; Yong-Jun Xiang; Bin Yuan; Hang-Zhou Wang; You-Xin Zhou
Journal:  Onco Targets Ther       Date:  2017-08-31       Impact factor: 4.147

3.  Cytotoxic effects of auraptene against a human malignant glioblastoma cell line.

Authors:  Amir R Afshari; Mostafa Karimi Roshan; Mohammad Soukhtanloo; Ahmad Ghorbani; Farzad Rahmani; Mohammad Jalili-Nik; Mohammad Mahdi Vahedi; Azar Hoseini; Hamid R Sadeghnia; Hamid Mollazadeh; Seyed Hadi Mousavi
Journal:  Avicenna J Phytomed       Date:  2019 Jul-Aug

4.  Auraptene-induced cytotoxicity mechanisms in human malignant glioblastoma (U87) cells: role of reactive oxygen species (ROS).

Authors:  Amir R Afshari; Mohammad Jalili-Nik; Mohammad Soukhtanloo; Ahmad Ghorbani; Hamid R Sadeghnia; Hamid Mollazadeh; Mostafa Karimi Roshan; Farzad Rahmani; Hamed Sabri; Mohammad Mahdi Vahedi; Seyed Hadi Mousavi
Journal:  EXCLI J       Date:  2019-07-30       Impact factor: 4.068

Review 5.  Characterization of the Golgi scaffold protein PAQR3, and its role in tumor suppression and metabolic pathway compartmentalization.

Authors:  Lan Lei; Zhe-Nan Ling; Xiang-Liu Chen; Lian-Lian Hong; Zhi-Qiang Ling
Journal:  Cancer Manag Res       Date:  2020-01-16       Impact factor: 3.989

6.  PAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancer.

Authors:  Xiaohui Li; Mengfei Li; Dong Chen; Gongning Shi; Hui Zhao
Journal:  Arch Med Sci       Date:  2017-12-13       Impact factor: 3.318

7.  PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability.

Authors:  Ling Jin; Laigen Tong
Journal:  Immun Inflamm Dis       Date:  2021-05-06

8.  Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis.

Authors:  Chunyu Zhang; Pan Liu; Jiaming Huang; Yuandong Liao; Chaoyun Pan; Junxiu Liu; Qiqiao Du; Tianyu Liu; Chunliang Shang; Shiyin Ooi; Run Chen; Meng Xia; Hongye Jiang; Manman Xu; Qiaojian Zou; Yijia Zhou; Hua Huang; Yuwen Pan; Li Yuan; Wei Wang; Shuzhong Yao
Journal:  Cell Death Dis       Date:  2021-09-29       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.